{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:21:40Z","timestamp":1781788900628,"version":"3.54.5"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:p>Anterior prostate cancer (APC) has been considered an indolent tumor, most commonly arising in the transition zone (TZ). More recently, detection of APC has been facilitated through multiparametric magnetic resonance imaging and improved biopsy techniques, enabling earlier detection. The pathologic features and clinical significance of pure APC in a large contemporary series of well-characterized tumors have, to date, not been elucidated. Cases with APC defined as cancer present anterior to the urethra only were identified from 1761 consecutive radical prostatectomy specimens accessioned between January 2015 and August 2016. The clinicopathologic features of these cases were compared with those of pure posterior prostate cancer (PPC) and the features of anterior peripheral zone (APZ) cancers were compared with those of TZ cancers. In addition, the tumor series from 2015 to 2016 was compared with a cohort of 1054 patients accessioned before the utilization of multiparametric magnetic resonance imaging in the routine workup of patients with prostate cancer. In the 2015-2016 series, there were 188 (10.7%) patients with APC compared with 5.4% in the series from the pre\u2013multiparametric magnetic resonance imaging era. No difference was observed between APC and PPC with regards to patient age or mean serum prostate-specific antigen at presentation. Mean tumor volume and positive surgical margin (PSM) rates were significantly higher in APC. In contrast, PPC was more commonly high grade with more frequent extraprostatic extension (EPE). None of the cases of APC had infiltration of the seminal vesicle or lymph node involvement, in contrast to PPC, with almost 14% of cases in each category. The 3- and 5-year biochemical recurrence-free survival was significantly higher in APC when compared with PPC, although this was not retained on multivariable analysis which included tumor location. On division of APCs according to anatomic zone of origin, 45% were APZ cancer and 37% TZ cancer. On comparison of APZ and TZ cancers, there were no significant differences in mean age and serum prostate-specific antigen at presentation as well as tumor volume, Gleason score, and PSM rate. High-grade malignancy (Gleason score &gt;3 + 4=7) was seen in 26% of TZ cancers which compared with 44% of APZ cancers and 56% of PPC cancers. The rate of EPE was significantly higher in APZ when compared with TZ cancer (<jats:italic toggle=\"yes\">P&lt;<\/jats:italic>0.0005); however, the biochemical recurrence rate was not significantly different between the groups. The prevalence of APC in radical prostatectomy specimens has increased in recent times, in association with earlier detection at a stage amenable to curative surgical treatment. APC, when compared with PPC, is less commonly high grade with less frequent EPE, despite the APC group having larger tumors and a higher PSM rate at presentation. However, not all anterior cancers are indolent. Anterior cancers are more commonly seen in the APZ than the TZ and APZ cancers appear more locally aggressive than TZ cancers.<\/jats:p>","DOI":"10.1097\/pas.0000000000002042","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T12:02:44Z","timestamp":1681473764000},"page":"701-708","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Clinicopathologic Significance of Anterior Prostate Cancer"],"prefix":"10.1097","volume":"47","author":[{"given":"Hemamali","family":"Samaratunga","sequence":"first","affiliation":[{"name":"Aquesta Uropathology"},{"name":"University of Queensland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Egevad","sequence":"additional","affiliation":[{"name":"Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Yaxley","sequence":"additional","affiliation":[{"name":"University of Queensland"},{"name":"Department of Pathology and Molecular Medicine, Wesley Hospital, Brisbane"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulammite","family":"Johannsen","sequence":"additional","affiliation":[{"name":"Aquesta Uropathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian K.","family":"Le Fevre","sequence":"additional","affiliation":[{"name":"Aquesta Uropathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna L.","family":"Perry-Keene","sequence":"additional","affiliation":[{"name":"Aquesta Uropathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy","family":"Gianduzzo","sequence":"additional","affiliation":[{"name":"University of Queensland"},{"name":"Department of Pathology and Molecular Medicine, Wesley Hospital, Brisbane"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Chabert","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Medicine, Wesley Hospital, Brisbane"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Coughlin","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Medicine, Wesley Hospital, Brisbane"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Parkinson","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Medicine, Wesley Hospital, Brisbane"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boon","family":"Kua","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Medicine, Wesley Hospital, Brisbane"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Yaxley","sequence":"additional","affiliation":[{"name":"Redcliffe Hospital, Redcliffe, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Delahunt","sequence":"additional","affiliation":[{"name":"Aquesta Uropathology"},{"name":"Malaghan Institute of Medical Research, Wellington, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,4,14]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/pros.2990020105","article-title":"The zonal anatomy of the prostate","volume":"2","author":"McNeal","year":"1981","journal-title":"Prostate"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0022-5347(17)42293-2","article-title":"Stage A versus stage B adenocarcinoma of the prostate: morphological comparison and biological significance","volume":"139","author":"McNeal","year":"1988","journal-title":"J Urol"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/00000478-198812000-00001","article-title":"Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread","volume":"12","author":"McNeal","year":"1988","journal-title":"Am J Surg Pathol"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0046-8177(92)90106-D","article-title":"Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread","volume":"23","author":"McNeal","year":"1992","journal-title":"Hum Pathol"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/1097-0142(19900915)66:6<1225::AID-CNCR2820660624>3.0.CO;2-X","article-title":"Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate","volume":"66","author":"McNeal","year":"1990","journal-title":"Cancer"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/1097-0142(19910215)67:4+<1132::AID-CNCR2820671506>3.0.CO;2-K","article-title":"Prostate cancer: transrectal ultrasound and pathology comparison. A preliminary study of outer gland (peripheral and central zones) and inner gland (transition zone) cancer","volume":"15","author":"Lee","year":"1991","journal-title":"Cancer"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0022-5347(17)38003-5","article-title":"A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate","volume":"146","author":"Greene","year":"1991","journal-title":"J Urol"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1464-410X.1991.tb15394.x","article-title":"Relationship between clinical stage and histological zone of origin in early prostate cancer: morphometric analysis","volume":"68","author":"Greene","year":"1991","journal-title":"Br J Urol"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1464-410X.2004.05147.x","article-title":"Prostate cancers in the transition zone: part 2; clinical aspects","volume":"94","author":"Augustin","year":"2004","journal-title":"BJU Int"},{"key":"R10-20250608","first-page":"267","article-title":"Zonal origin of prostatic adenocarcinoma: are there biologic differences between transition zone and peripheral zone adenocarcinoma of the prostate gland?","volume":"19","author":"Grignon","year":"1994","journal-title":"J Cell Biochem Suppl"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/00313020310001619154","article-title":"Transition zone carcinoma of the prostate gland: a common indolent tumour type that occasionally manifests aggressive behaviour","volume":"35","author":"Shannon","year":"2003","journal-title":"Pathology"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/PAS.0b013e31812f7b27","article-title":"Anterior-predominant prostatic tumors: zone of origin and pathologic outcomes at radical prostatectomy","volume":"32","author":"Al-Ahmadie","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1590\/s1677-5538.ibju.2016.0335","article-title":"Does index tumor predominant location influence prognostic factors in radical prostatectomies?","volume":"43","author":"Billis","year":"2017","journal-title":"Int Braz J Urol"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.juro.2016.03.075","article-title":"Characteristics of anteriorly located prostate cancer and the usefulness of multiparametric magnetic resonance imaging for diagnosis","volume":"196","author":"Kim","year":"2016","journal-title":"J Urol"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41391-019-0199-1","article-title":"Clinicopathologic features and outcomes of anterior-dominant prostate cancer: implications for diagnosis and treatment","volume":"23","author":"Falzarano","year":"2020","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00345-013-1114-3","article-title":"Midterm oncological outcome and clinicopathological characteristics of anterior prostate cancers treated by endoscopic extraperitoneal radical prostatectomy","volume":"32","author":"Good","year":"2014","journal-title":"World J Urol"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1464-410X.2006.06578.x","article-title":"The clinical features of anterior prostate cancers","volume":"98","author":"Koppie","year":"2006","journal-title":"BJU Int"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0022-5347(17)37718-2","article-title":"Efficacy of transrectal ultrasound for identification of clinically undetected prostate cancer","volume":"146","author":"Terris","year":"1991","journal-title":"J Urol"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12032-015-0693-9","article-title":"Clinicopathologic characteristics of anterior prostate cancer (APC), including correlation with previous biopsy pathology","volume":"32","author":"Magers","year":"2015","journal-title":"Med Oncol"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.juro.2018.06.026","article-title":"Anterior localization of prostate cancer suspicious lesions in 1161 patients undergoing magnetic resonance imaging\/ultrasound fusion guided targeted biopsies","volume":"200","author":"Leyh-Bannurah","year":"2018","journal-title":"J Urol"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"573","DOI":"10.4111\/icu.20200159","article-title":"Complementing the active surveillance criteria with multiparametric magnetic resonance imaging","volume":"61","author":"Kim","year":"2020","journal-title":"Investig Clin Urol"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00345-020-03335-4","article-title":"Prognostic performance of magnetic resonance imaging-guided biopsy in defining prostate cancer anterior lesions","volume":"39","author":"Porreca","year":"2021","journal-title":"World J Urol"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/his.12262","article-title":"Total submission of pelvic lymphadenectomy tissues removed during radical prostatectomy for prostate cancer increases lymph node yield and detection of micrometastases","volume":"64","author":"Perry-Keene","year":"2014","journal-title":"Histopathology"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2559.2011.04003.x","article-title":"Gleason grading: past, present and future","volume":"60","author":"Delahunt","year":"2012","journal-title":"Histopathology"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.pathol.2019.05.001","article-title":"Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation","volume":"51","author":"Srigley","year":"2019","journal-title":"Pathology"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","article-title":"The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma","volume":"44","author":"van Leenders","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/00000478-200310000-00001","article-title":"A streamlined three-dimensional volume estimation method accurately classifies prostate tumors by volume","volume":"27","author":"Chen","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/modpathol.2010.158","article-title":"International Society of Urological Pathology (ISUP) consensus conference on handling and staging of radical prostatectomy specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease","volume":"24","author":"Magi-Galluzzi","year":"2011","journal-title":"Mod Pathol"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/modpathol.2010.155","article-title":"International Society of Urological Pathology (ISUP) consensus conference on handling and staging of radical prostatectomy specimens. Working group 5: surgical margins","volume":"24","author":"Tan","year":"2011","journal-title":"Mod Pathol"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/modpathol.2010.160","article-title":"International Society of Urological Pathology (ISUP) consensus conference on handling and staging of radical prostatectomy specimens. Working group 4: seminal vesicles and lymph nodes","volume":"24","author":"Berney","year":"2011","journal-title":"Mod Pathol"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-2559.2011.04004.x","article-title":"Anatomy of the prostate revisited: implications for prostate biopsy and zonal origins of prostate cancer","volume":"60","author":"Fine","year":"2012","journal-title":"Histopathology"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"198","DOI":"10.5507\/bp.2020.054","article-title":"Do not underestimate anterior prostate cancer","volume":"165","author":"Kudlackova","year":"2021","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"833","DOI":"10.5858\/arpa.2021-0104-OA","article-title":"Anterior or posterior prostate cancer tumor nodule location predicts likelihood of certain adverse outcomes at radical prostatectomy","volume":"146","author":"Hayee","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"R34-20250608","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/S0022-5347(05)67535-0","article-title":"An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics","volume":"163","author":"Noguchi","year":"2000","journal-title":"J Urol"},{"key":"R35-20250608","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.urology.2012.08.012","article-title":"Prostate cancers of different zonal origin: clinicopathological characteristics and biochemical outcome after radical prostatectomy","volume":"80","author":"Iremashvili","year":"2012","journal-title":"Urology"},{"key":"R36-20250608","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1097\/PAS.0b013e318172ee97","article-title":"Do prostatic transition zone tumors have a distinct morphology?","volume":"32","author":"Garcia","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R37-20250608","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0302-2838(01)00021-5","article-title":"Tumour grade, proliferation, apoptosis, microvessel density, p53, and bcl-2 in prostate cancers: differences between tumours located in the transition zone and in the peripheral zone","volume":"41","author":"Erbersdobler","year":"2002","journal-title":"Eur Urol"},{"key":"R38-20250608","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/carcin\/bgv051","article-title":"Molecular differences in transition zone and peripheral zone prostate tumors","volume":"36","author":"Sinnott","year":"2015","journal-title":"Carcinogenesis"},{"key":"R39-20250608","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/his.12153","article-title":"TMPRSS2-ERG rearrangement in dominant anterior prostatic tumours: incidence and correlation with ERG immunohistochemistry","volume":"63","author":"Gopalan","year":"2013","journal-title":"Histopathology"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002042","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T21:00:18Z","timestamp":1749416418000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002042"}},"subtitle":["Comparison With Posterior Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging"],"short-title":[],"issued":{"date-parts":[[2023,4,14]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002042","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,14]]}}}